Evolving Management of EGFR Exon20+ NSCLC: Future Directions in Care

Video

Closing out their discussion on EGFR Exon20+ non–small cell lung cancer, Joshua Sabari, MD, and Misako Nagasaka, MD, share excitement for future evolutions in the treatment paradigm.

Recent Videos
1 expert in this video
1 expert in this video
1 expert in this video
1 expert in this video
Related Content